These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 15036719

  • 21. Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial.
    Lajolo PP, de Camargo B, del Giglio A.
    Am J Clin Oncol; 2009 Feb; 32(1):23-6. PubMed ID: 19194119
    [Abstract] [Full Text] [Related]

  • 22. [Clinical effects of granisetron and methylprednisolone against nausea, vomiting and anorexia induced by cisplatin].
    Kawashima T, Wada T, Morita N, Ohmata T, Miyata K, Sakamoto T.
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2043-8. PubMed ID: 8215479
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Antiemetic combination of metoclopramide and methylprednisolone for cisplatin-induced vomiting].
    Saito H, Amano H, Yasuda Y, Tsunekawa H, Fujimoto K, Yoshii S, Shimokata K.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1980-2. PubMed ID: 4051514
    [Abstract] [Full Text] [Related]

  • 25. The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery.
    White PF, Tang J, Hamza MA, Ogunnaike B, Lo M, Wender RH, Naruse R, Sloninsky A, Kariger R, Cunneen S, Khalili T.
    Anesth Analg; 2006 May; 102(5):1387-93. PubMed ID: 16632815
    [Abstract] [Full Text] [Related]

  • 26. [Antiemetic efficacy of granisetron in the treatment of pediatric cancer--(1). Clinical evaluation of granisetron at a dose of 40 micrograms/kg].
    Hirota T, Honjo T, Kuroda R, Saeki K, Katano N, Sakakibara Y, Shimizu H, Fujimoto T.
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2201-5. PubMed ID: 8251030
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Therapeutic potential of Granisetron (Kitryl) for the prevention of nausea and vomiting induced by cytostatic drugs].
    Gershanovich ML, Beresneva IA.
    Vopr Onkol; 1998 Nov; 44(2):225-8. PubMed ID: 9615833
    [Abstract] [Full Text] [Related]

  • 30. Granisetron-dexamethasone combination for multiple day cisplatin.
    Pronzato P, Losardo PL, Vaira F, Vigani A, Landucci M, Ghio E.
    Anticancer Res; 1995 Nov; 15(5B):2261-3. PubMed ID: 8572634
    [Abstract] [Full Text] [Related]

  • 31. Granisetron (Kytril) plus dexamethasone for antiemetic control in bone marrow transplant patients receiving highly emetogenic chemotherapy with or without total body irradiation.
    Abbott B, Ippoliti C, Hecth D, Bruton J, Whaley B, Champlin R.
    Bone Marrow Transplant; 2000 Jun; 25(12):1279-83. PubMed ID: 10871733
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. About the antiemetic effectivity of granisetron in chemotherapy-induced acute emesis: a comparison of results with intravenous and oral dosing.
    Lehoczky O.
    Neoplasma; 1999 Jun; 46(2):73-9. PubMed ID: 10466429
    [Abstract] [Full Text] [Related]

  • 36. Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
    Cheirsilpa A, Sinthusake T, Songsakkaesorn A, Visawaprasit S, Chulaka K, Changkuingdee N.
    Jpn J Clin Oncol; 2005 Dec; 35(12):695-9. PubMed ID: 16319109
    [Abstract] [Full Text] [Related]

  • 37. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
    Walsh T, Morris AK, Holle LM, Callander N, Bradshaw P, Valley AW, Clark G, Freytes CO.
    Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of granisetron in the antiemetic control of nonsurgical intestinal obstruction in advanced cancer: a phase II clinical trial.
    Tuca A, Roca R, Sala C, Porta J, Serrano G, González-Barboteo J, Gómez-Batiste X.
    J Pain Symptom Manage; 2009 Feb; 37(2):259-70. PubMed ID: 18789638
    [Abstract] [Full Text] [Related]

  • 39. [Anti-emetic treatment for patients with non-small cell lung cancer after chemotherapy, usefulness of preventive combination of anti-emetic agents and importance of psychiatric aspect of patients].
    Inoue S, Endo K, Ichimura H, Endo K.
    Gan To Kagaku Ryoho; 1999 May; 26(6):813-9. PubMed ID: 10410151
    [Abstract] [Full Text] [Related]

  • 40. Clinical evaluation of granisetron as an inhibitor of nausea and vomiting induced by oral anticancer drugs.
    Togo S, Akiyama H, Yamaguchi S, Ichikawa Y, Ike H, Shimada H.
    Oncol Rep; 2002 May; 9(2):277-82. PubMed ID: 11836592
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.